Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11844841
Dosing regimens and related compositions and methods
granted -
US 11845990
Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype
granted -
US 11844771
Methods of treating acute respiratory distress syndrome using colchicine
granted -
US 11845931
CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation
granted -
US 11844799
Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic
granted -
US 11844874
Lyophilized polymer scaffold compositions, processes for preparation and use in anabolic wound repair
granted -
US 11844764
Agitation process for preparing a carbetocin drug product
granted -
US 11845808
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 11844801
Oral compositions of MK2 pathway inhibitor for treatment of immune conditions
granted -
US 11844816
Compositions and methods for augmenting the nasal microbiome
granted -
US 11844805
Formulations of testosterone and methods of treatment therewith
granted -
US 11844843
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
granted -
US 11844867
Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11844857
Treating gynecological malignancies with deployable implants
granted -
US 11844779
PKC-Delta-I inhibitor formulations and uses thereof
granted -
US 11845726
C4-carbonothioate-substituted tryptamine derivatives and methods of using
granted -
US 11845800
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted -
US 11845787
DNA antibody constructs for use against HIV
granted -
US 11845963
HSD17B13 variants and uses thereof
granted -
US 11845959
Identification of factor that promotes human HSC self-renewal
granted -
US 11845778
Prefusion PIV F immunogens and their use
granted -
US 11845957
Models of tauopathy
granted -
US 11845937
RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use
granted -
US 11845965
Regulation of gene expression using engineered nucleases
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.